sumatriptan

sumatriptan (SUMATRIPTAN GALPHARM) is an FDA-listed pharmaceutical active ingredient. Associated with Tonix Pharmaceuticals Holding. Route of administration: oral. Current US regulatory status: approved.

SUMATRIPTAN GALPHARM is a marketed brand name for sumatriptan. Check FDA Drugs@FDA for the current US label holder and prescribing information.

sumatriptan has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.